Conditions: Fungal Infection
Keywords: refractory or first line medication intolerable invasive fungal infection
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 63
Healthy volunteers: no

Brief summary:
The purpose of this multicenter, open label study, is to evaluate the safety and efficacy of a 12-week treatment with Posaconazole Oral Suspension in participants with IFI

Detailed description:

Arms:
arm 1: Posaconazole 400 mg twice a day (BID) oral suspension for 12 weeks

Interventions: intervention 1: Posaconazole
Intervention descriptions: intervention 1: 400mg BID oral suspension for 12 weeks

Protocol document: